Who owns INMED PHARMACEUTICALS INC?
- Ticker: INM
- CUSIP Number: 457637700
Tip: Access positions for across all investors
Analyze quarterly positions in Inmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Inmed Pharmaceuticals stock
Who bought or sold INMED PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sabby Management | 202k | $214k | -8% | Dec 2025 |
|
| Citadel Advisors | 47k | $30k | 100% | Mar 2026 |
|
| Two Sigma Securities | 19k | $12k | 100% | Mar 2026 |
|
| Susquehanna International | 13k | $14k | 100% | Dec 2025 |
|
| UBS Group | 8.1k | $5.2k | 2040% | Mar 2026 |
|
| Private Wealth Management Group | 5.0k | $3.2k | 100% | Mar 2026 |
|
| SBI Securities | 300.00 | $192.990000 | 0% | Mar 2026 |
|
| Banque Cantonale Vaudoise | 6.00 | $0 | 0% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 2.00 | $2.000000 | 0% | Mar 2026 |
|
Who sold out of Inmed Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Sep 2025 | 20k | $45k |
| Renaissance Technologies | Sep 2025 | 17k | $37k |
| Jane Street | Dec 2025 | 12k | $13k |